ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 180 filers reported holding ARIAD PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $26,045,000 | -16.5% | 2,093,677 | -8.1% | 0.01% | -20.0% |
Q3 2016 | $31,203,000 | +90.3% | 2,279,302 | +2.7% | 0.01% | +100.0% |
Q2 2016 | $16,401,000 | +21.4% | 2,219,448 | +4.1% | 0.01% | +25.0% |
Q1 2016 | $13,510,000 | +3.2% | 2,133,052 | +1.8% | 0.00% | 0.0% |
Q4 2015 | $13,091,000 | +8.2% | 2,094,590 | +1.1% | 0.00% | 0.0% |
Q3 2015 | $12,099,000 | -22.4% | 2,071,567 | +9.8% | 0.00% | -20.0% |
Q2 2015 | $15,596,000 | -7.4% | 1,885,869 | -7.7% | 0.01% | 0.0% |
Q1 2015 | $16,834,000 | +21.7% | 2,042,956 | +1.5% | 0.01% | +25.0% |
Q4 2014 | $13,827,000 | +22.6% | 2,012,634 | -3.7% | 0.00% | 0.0% |
Q3 2014 | $11,280,000 | +79.8% | 2,088,998 | +112.2% | 0.00% | +100.0% |
Q2 2014 | $6,272,000 | -21.1% | 984,610 | -0.2% | 0.00% | -33.3% |
Q1 2014 | $7,952,000 | +47.3% | 986,531 | +24.6% | 0.00% | +50.0% |
Q4 2013 | $5,399,000 | -62.3% | 791,706 | +1.6% | 0.00% | -60.0% |
Q3 2013 | $14,333,000 | -1.4% | 778,972 | -6.3% | 0.01% | 0.0% |
Q2 2013 | $14,536,000 | – | 831,120 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 12,850,000 | $175,916,000 | 40.51% |
Consonance Capital Management LP | 8,695,742 | $119,045,000 | 11.46% |
Tamarack Advisers, LP | 3,700,000 | $49,358,000 | 7.76% |
Opaleye Management Inc. | 1,045,000 | $14,306,000 | 7.49% |
Granite Point Capital Management, L.P. | 457,415 | $6,262,000 | 2.44% |
Redmile Group, LLC | 2,138,471 | $29,276,000 | 2.33% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 206,010 | $2,820,000 | 2.17% |
Palo Alto Investors LP | 2,587,617 | $35,424,000 | 2.06% |
PRICE MICHAEL F | 940,000 | $12,869,000 | 1.71% |
HighVista Strategies LLC | 638,086 | $8,735,000 | 1.62% |